Dr. Rolf E Lindquist, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 303 E 3rd St, Grand Marais, MN 55604 Phone: 218-387-2774 |
Alyssa Anne Hedstrom, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 303 E 3rd Street, Grand Marais, MN 55604 Phone: 218-387-2774 Fax: 218-387-1393 |
Dr. Patrick Wesley Pawlowski, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 303 E. 3rd Street, Grand Marais, MN 55604 Phone: 630-235-8447 Fax: 630-235-8447 |
News Archive
PHT Corporation announced the general availability of the LogPad App™ System that collects compliant patient data using Apple and Android smartphones. The LogPad App gives sponsors and CROs the flexibility to deploy Phase II, III, and IV clinical studies plus post market and observational research to massive patient populations.
Everyone hopes that one day stem cell-based regenerative medicine will help repair diseased tissue. Before then, it may be necessary to decipher the epigenetic signals that give stem cells their unique ability to self-renew and transform them into different cell types.
Lying awake in bed plagues everyone occasionally, but for those with seasonal affective disorder, sleeplessness is routine. University of Pittsburgh researchers report in the Journal of Affective Disorders that individuals with seasonal affective disorder -a winter depression that leads to loss of motivation and interest in daily activities-have misconceptions about their sleep habits similar to those of insomniacs.
Researchers in Israel have conducted a study exploring the behavioral and psychological impact of the coronavirus disease 19 (COVID-19) pandemic in an effort to understand the biological and environmental factors that may influence how individuals cope with the crisis.
VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 agonists and antagonists for the treatment of cancer, respiratory and autoimmune diseases, announced today the presentation of positive clinical results from its randomized, placebo-controlled clinical trial evaluating VTX-1463 for the treatment of allergic rhinitis.
› Verified 2 days ago